WO2008025762A1 - Annular mesh - Google Patents

Annular mesh Download PDF

Info

Publication number
WO2008025762A1
WO2008025762A1 PCT/EP2007/058912 EP2007058912W WO2008025762A1 WO 2008025762 A1 WO2008025762 A1 WO 2008025762A1 EP 2007058912 W EP2007058912 W EP 2007058912W WO 2008025762 A1 WO2008025762 A1 WO 2008025762A1
Authority
WO
WIPO (PCT)
Prior art keywords
struts
mesh
zig
zag
stenting
Prior art date
Application number
PCT/EP2007/058912
Other languages
French (fr)
Inventor
Thilo Wack
Original Assignee
Angiomed Gmbh & Co. Medizintechnik Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiomed Gmbh & Co. Medizintechnik Kg filed Critical Angiomed Gmbh & Co. Medizintechnik Kg
Priority to US12/438,527 priority Critical patent/US9254207B2/en
Priority to EP07802941A priority patent/EP2056744B1/en
Priority to DE602007006026T priority patent/DE602007006026D1/en
Priority to CA2690060A priority patent/CA2690060C/en
Publication of WO2008025762A1 publication Critical patent/WO2008025762A1/en
Priority to US15/018,568 priority patent/US9770348B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/89Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/92Stents in the form of a rolled-up sheet expanding after insertion into the vessel, e.g. with a spiral shape in cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • A61F2002/91541Adjacent bands are arranged out of phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band

Definitions

  • This invention relates to an annular mesh that defines a lumen that surrounds a longitudinal axis of the mesh, the mesh being capable of sustaining a radially outwardly- directed resistive force even while flexing in response to externally applied forces that bend its longitudinal axis out of a straight line, the mesh being composed of struts, the struts defining a plurality of repeating unit cells each with a closed periphery, a string of said unit cells providing each of a plurality of stenting loops that surround said lumen .
  • Such an annular mesh is the operative part of a bodily prosthesis that is commonly known as a stent.
  • the purpose of the stent is to maintain a bodily lumen patent and, to do this, the mesh of the stent must resist the radially inward pressure of the bodily tissue that would otherwise close the bodily lumen.
  • annular mesh stents As usage of annular mesh stents becomes ever more sophisticated, the demands for the annular mesh to be flexible, even while it resists radially inward pressure from bodily tissue, also increase. Stent designers have found it difficult to increase flexibility (in response to requirements for the longitudinal axis of the mesh to bend out of a straight line) while retaining adequate resistance to radially inward forces on the mesh.
  • the other characteristic form of a stent mesh is the helical stent, in which stenting struts proceed as zig zags around a spiral path from one end of the stent to the other. Connectors may be provided at spaced intervals, between successive turns of the spiral, for locational integrity of the mesh.
  • a spiral form mesh has inherently more flexibility, and less resistance to radially inwardly directed forces, than is the case with a stack of closed stenting loops arranged transverse to the longitudinal axis of the annulus of the stent.
  • helical stents see for example, EP-A-1245203 and 870483, US Patents 6053940 and WO publications 2002/049544 and 01/01889.
  • stenting loops advance around the circumference of the stent lumen as a zig-zag of stent struts that alternate with zones of inflection. Taking the line that is the bisector of the angle between two adjacent struts of a zig-zag loop, that bisector will likely lie parallel or near parallel to the longitudinal axis of the stent lumen, in any ring stent. Conversely, in any helical stent, that bisector will likely lie at an angle to the longitudinal axis, that is larger as the helical pitch of the stenting loops gets larger.
  • the present inventor recognized the advantages in retaining something of the flexibility of the spiral stent mesh, together with something of the radial force capability of closed stenting loops . This he accomplishes by providing a unit cell for the stent matrix, which resembles that of a ring stent yet, when assembled into the stent matrix, yields a spiral wind of unit cells around the longitudinal axis of the stent .
  • a ring stent is like a rook (castle) .
  • the zig-zag stenting ring advances around the circumference strictly perpendicular to the longitudinal axis of the stent lumen.
  • a helical stent is like the bishop. He advances in a straight line again, but slanting to the long axis of the lumen.
  • Embodiments of the present invention exhibit a path of advance of the zig-zag stenting loops like the way the knight moves - forwards, then across, then forwards again,
  • successive stenting loops are joined end- to-end in a continuous spiral around the longitudinal axis of the annulus , but the successive turns of the spiral are made out of a plurality of unit cells, each with a closed periphery.
  • the closed cells contribute a greater capability than a pure spiral stent to resist externally imposed radially inwardly directed forces, while the spiral architecture of the mesh contributes more flexibility than a closed loop stent mesh.
  • Not all struts that make up the periphery of the unit cell share the same length. By introducing a strut length increment within the periphery, the invention can be realised.
  • the struts typically exhibit a constant incremental shift of the position of the struts along the longitudinal axis of the stent.
  • the periphery of the unit cell is characterised by a departure form this degree of uniformity.
  • each such strut has a length direction that is parallel to the longitudinal axis. In other embodiments, the length direction of the strut is not parallel to the longitudinal axis.
  • unit cells of prior art closed loop stenting meshes it is often possible to identify a unit cell that exhibits mirror symmetry about a plane that includes the longitudinal axis of the mesh.
  • the unit cell typically lacks such mirror symmetry.
  • the unit cell of the present invention typically exhibits 180° rotational symmetry about a rotational axis that is perpendicular to the longitudinal axis of the annular mesh and also intersects the longitudinal axis of the annulus.
  • simplicity is a desirable objective. If only for this reason, stent unit cells with 180° rotational symmetry are preferred.
  • the mesh of the present invention finds particular application in a stent for transluminal implantation in a body, and that stent may be, for example, a self-expanding stent or a balloon expansible stent .
  • the annular mesh is formed from a sheet-form workpiece and, although that workpiece could be a flat sheet, it is desirably in the form of a seamless tube.
  • a computer-controlled laser is employed to cut slits in a seamless tubular workpiece held on a jig and, typically, the slits are parallel to the long axis of the workpiece.
  • annular mesh in accordance with the present invention typically displays a single spiral of the unit cells, that exhibits a pitch that corresponds to the length of the unit cell in the longitudinal axis direction of the annulus , this need not be so.
  • meshes that exhibit a double spiral but this is unlikely to be preferred, because of the constraints which such a design imposes on the dimensions of the unit cell.
  • the spiral pattern mesh will exhibit connectors regularly arranged around the circumference of the annulus with the view to maintaining desired axial spacing between successive adjacent turns of the spiral.
  • these connectors are staggered circumferentially with respect to the connectors joining the next adjacent pair of stenting loops around the annulus, for optimising the balance between flexibility and structural integrity.
  • One way of recognising the hybrid nature of the stents according to the present invention is to contemplate the orientation of the bisector of the angle between the struts that form any one zig-zag of the mesh. It will tend to be parallel or near parallel to the longitudinal axis of the stent lumen, more like a ring stent than a helical stent. Yet, overall, the mesh of the present stents is recognisably a helical pattern rather than a stack of closed stenting loops .
  • annular mesh of the present invention will be useful not only for bare stents but also for the stent meshes used in grafts, or other annular meshes used in surgical tools such as vascular filters, in which the mesh would be used to carry a filter membrane .
  • Figs. 1 to 4 each show a view of an annular mesh, opened out flat in a radially expanded configuration
  • Fig. 5 shows a fragment of a laser cutting pattern on a tubular workpiece laid out flat
  • Fig. 6 shows at smaller scale the complete workpiece of Fig. 5;
  • Fig. 7 is a photograph of part of the Fig. 6 workpiece after radial expansion
  • Fig. 8 is a schematic representation of the strut pattern of Fig 7.
  • Fig. 9 is a diagram of the way three chess pieces more over a chessboard.
  • the relevant rotational axis is one that extends perpendicularly upwards out of the plane of the drawing page.
  • FIG. 1 we can ascertain in the drawing a portion of the mesh that includes four slanting zig-zag strings of stenting struts, marked A, B, C and D.
  • the repeating unit cell is marked Ul and there are two such unit cells needed to make up one complete turn around the circumference of the annulus .
  • the zig-zag strings A and B are bridged by only two connector struts 10 and 12, it being appreciated that strut 12 between strings A and B at the foot of the page is the same as strut 16 between strings C and D at the top of the page of drawing Fig. 1 connecting zig-zag strings C and D.
  • zig-zag strings C and D are connected by only two struts 14 and 16.
  • the connector struts 18 and 20 that connect zig-zag strings B and C are circumferentially staggered relative to the struts 10, 12, 14 and 16 that make up parts of the periphery of the unit cells in the next adjacent stenting loops, formed by strings A and B and strings C and D respectively.
  • There are two unit cells Ul lying between zig-zag string B and zig-zag string C. One of those unit cells is evident, in full, in Fig. 1. The other is just as much a closed periphery cell, even though in Fig. 1 it appears in two separate halves, both with an incomplete periphery, and marked U2t at the top of the page and U2b at the bottom of the page. In other words U2t + U2b Ul.
  • the drawing shows the annulus in a radially expanded disposition, ready to resist radially inwardly directed forces tending to reduce the diameter of the lumen surrounded by the annular mesh.
  • the mesh is representative of the strut matrix of a transluminally delivered stent
  • the disposition of the struts shown in Fig. 1 when the strut is in a radially small transluminal delivery disposition by compressing the strut arrangement presented in Fig. 1, in a North-South direction on the drawing page (supposing North is at the top of the page) .
  • the skilled reader will appreciate that all of the struts concertina or fold down to a disposition in which they are lying more or less horizontally, East-West, on the drawing page.
  • Such a strut matrix can be made from a seamless tubular workpiece, by laser cutting slits in the workpiece, to leave struts having the wall thickness of the annular workpiece, all such slits, and all such struts, having a length direction parallel to the East-West longitudinal axis of the annular mesh shown in the drawing .
  • Fig. 1 is of unit cells with shared boundaries, obviating the need for any connector struts between adjacent unit cells that do not themselves constitute a part of the closed periphery of one or other unit cell of the matrix.
  • struts 18 an 20 as connectors, connecting like unit cells lying between zig-zag strings A and B with end cells located between zigzag strings A and B.
  • struts 18 and 20 are themselves part of the closed periphery of unit cells of the same form, lying between zig-zag strings B and C.
  • Fig. 1 Also evident from Fig. 1 is that not all the stenting struts in each zig-zag string A, B, C, D have the same length. Struts such as strut 22 are notably short. In each unit cell Ul, we can discern two of the short struts 22. Rotating the unit cell by 180° about a rotational axis perpendicular to the plane of the page will bring each of the two short struts to the location of the other of the two short struts in any of the unit cells. Turning to Fig. 2, presented is a unit cell that exhibits around its periphery a larger number of struts than is evident from the unit cell of Fig. 1. In Fig.
  • unit cell U3 has 180° rotational symmetry but not mirror plane symmetry. Imagining the mesh compressed in the North- South direction on the page, one can appreciate that, in the radially compressed disposition of the mesh, all slits and all struts extend East-West on the page, parallel to the longitudinal axis of the annulus.
  • Fig. 3 differs from the designs of Fig. 1 and Fig. 2 in that the adjacent loops of unit cells U4 are spaced from each other longitudinally (East-West in the drawing) but joined to each other longitudinally by connector struts 40, of which there are four, spaced by equal intervals around the circumference of the annulus.
  • each unit cell U4 has around its periphery four more stenting struts, two in each zig-zag string. This extra zigzag in the circumferential length (North-South in the drawing) of each unit cell U4 provides the scope for placing connector struts 40 at locations intermediate the circumferential end struts 42, 44 of each of the unit cells.
  • each stenting loop of four unit cells U4 are not circumferentially staggered relative to the cells of the axially next adjacent string of unit cells U4.
  • lying axially between the two shown strings of unit cells U4 is a string of 4 unit cells U5 that are alike with each other but different from the unit cell U4.
  • any unit cell U4 looking along the longitudinal axis of the annulus, is of other unit cells U4 , located (in the drawing) due East and due West of the viewing position, without any circumferential stagger towards the North or the South. Nevertheless, by virtue of the different length struts, any particular peak point of inflection 46 faces in the longitudinal direction of the annulus a valley 48 between two struts 50 and 52 of the next adjacent unit cell linked by the connector strut 40.
  • the arrangement of unit cells and connector struts is relatively simple ⁇ all struts are cut straight) yet the "peak-to-valley" configuration in the radially expanded disposition shown in Fig.
  • struts 40 are on a line that slants relative to the longitudinal axis of the annulus, when the mesh is in the expanded disposition as shown in Fig. 3, that same strut 40, in the radially compact disposition of the mesh will be parallel to the longitudinal axis.
  • the mesh of Fig. 3 is one that can be made from a seamless tubular workpiece by cutting slits all parallel to the long axis of the tube, to create struts all parallel to the long axis of the tube, which only depart from such a parallel (East-West in Fig. 3 ⁇ direction, when the mesh is radially expanded up into the opened out zig-zag configuration to be seen from Fig. 3. Again, this is a win for simplicity, this time in the slit- and strut-cutting part of the manufacturing process.
  • the unit cell of Fig. 4, U6 is not unlike the one presented in Fig. 2.
  • the most evident difference is the orientation of the strut 50 that is shared between two adjacent unit cells of the stenting loop.
  • the connector strut 50 is slanting to the long axis of the annulus when viewed in the expanded configuration of Fig. 4, once again, concertina compression North-South of the mesh of Fig. 4 down to the radially compact disposition in which an annular workpiece can be slitted to provide the strut seen in Fig. 4 will bring strut 50 into an orientation in which it is parallel to the East-West longitudinal axis of the annulus of the Fig. 4 mesh.
  • Figs, 2 and 4 share with those of Fig. 1 the characteristic that the peripheral stenting struts of each unit cell (except connector strut 50), are shared with the adjacent unit cell lying respectively East and West of the unit cell seen in Fig. 4, that is, next adjacent in the longitudinal direction of the annulus of the mesh.
  • Struts 50 are connectors, but also struts contributing to the closed periphery of a unit cell U5. There are no connectors in the annular meshes of any of Figs. 1, 2 and 4 which are not also struts that are part of the periphery and closed circumference of a unit cell of the matrix.
  • a stent framework can e constructed, in sequence, unit cells of Figure 1 connected to the unit cells of Figure 2, which are connected to the unit cells of Figure 3, which are also connected to the unit cells of Figure 4, i.e., Figl-Fig4- Fig2-Fig3, Fig4-Figl-Fig2-Fig3 and so on in at least 24 different permutations.
  • Fig. 6 shows a stent matrix from one end to the other, laid out flat.
  • Fig. 5 shows a middle portion of the length of the Fig. 6 stent matrix.
  • each stenting strut having a constant width in the circumferential direction of the matrix.
  • the struts 110 has a lead line and reference number, only one of the laser cut slits 112 and in only one location, reference W, the characteristic circumferential width of the stenting strut as indicated.
  • the matrix displays a slanting or helical pattern, in that each sequence of stenting struts alternating with points of inflection 114, is seen to lie between notional slanting lines Sl and S2 that lie at an acute angle to the longitudinal axis of the matrix.
  • a so-called "ring stent” would display stenting rings between two notional lines that are perpendicular to the longitudinal axis of the stent.
  • Each of the inclined zig-zag stenting loops is joined to the adjacent stenting loop by connector struts 116 that are seen to have a circumferential width of 2W and that extend across the slanting lines Sl and S2 with a length direction parallel to the long axis of the stent.
  • connector struts 116 there are four such connector struts 116 in each turn of the stenting loop around the axis of the matrix. It is part of the advantage of the invention that it can yield stents with a high flexibility even through stenting loops are connected by a plurality of simple short straight axial connectors.
  • holes there are “holes” 118 in the matrix, that is, through apertures in the stent wall, of substantial open area, even in the as cut matrix, which holes also span the slant line Sl, S2 and lie between two adjacent stenting loops. These holes 118 arise during the laser cutting of the stent matrix, after the laser has cut all around the periphery of hole 118. See our own earlier WO 2001/032102 for a description of the creation of similar holes.
  • each stenting loop 120 that lies between two slanting lines, for example Sl and S2 , exhibits loop portions with a constant length of laser cut 112 and stenting strut 110.
  • these cuts, struts and points of inflection 114 present an appearance of part of a ring stent with its stenting loops perpendicular to the long axis of the stent. They are interspersed by occasional, shorter than usual struts 122 that are contiguous with a connector strut 116.
  • the skilled reader will appreciate that the response of a strut to any particular applied bending stress depends on the length of that strut.
  • FIG. 6 we see in particular an architecture at each end of the stent, between the slanting architecture of the main length of the stent and the end stenting rings 130, one at each end of the stent.
  • Connecting the slanting architecture to the perpendicular end ring are four connector struts distributed evenly around the circumference of the lumen, but these four struts, 132, 134, 136 and 138 are of different lengths and widths.
  • the reader will appreciate that the meeting of a spiral pattern and a perpendicular end ring is necessarily going to give rise to "holes" between the slanting and perpendicular architecture that are unsymmetrical .
  • the holes in the present case are referenced 140, 142, 144 and 146.
  • Hole 140 in particular, is relatively large in the axial direction.
  • Fig. 7 is useful because it is a photomicrograph of a real embodiment, so that it gives an impression of the way in which shorter struts bend less than longer ones.
  • Fig. 8 is schematic and does not show this reality. Its suggestion that every strut is inclined at the same constant angle to the longitudinal axis of the stent lumen, in the expanded configuration, is not the reality. Neither does Fig.8 preserve the relative scale of the length difference between the regular strut length 110 and the occasional "special" strut length 122.
  • Fig. 8 is useful in showing how points of inflection 114 no longer face each other head on, across a short axial gap.
  • points of inflection would be "nose-to- nose" especially on the inside of a bend when the stent is bent into a banana shape, as might happen in normal use in peripheral vascular applications, we see the points of inflection to be circumferentially staggered relative to each other so that there is a minimal risk of them impacting nose- to-nose, on the inside of the bend, in use of the stent.
  • Figure 8 serves another useful purpose, to render more easily visible the hybrid (intermediate between "ring” and “spiral” stent) nature of the embodiment.
  • each node 160 is also a point of inflection 114 between a regular stenting strut 110 and one of the occasional shorter struts 122.
  • each portion of the zig-zag string, between any two adjacent nodes A-B, B- C, C-D, is a portion of a stenting ring that is orientated perpendicular to the stent axis.
  • Each circumferential portion A to B, B to C, C to D is axially stepwise offset from its neighbour portions, the step occurring at the three leg node. The same can be discerned in the other drawing figures but the schematic representation of Fig. 8 makes it a little easier to recognise. Making, in Fig. 8, the short struts 122 exaggeratedly shorter also helps to reveal the effect.
  • nodes 160B and 160D are each a member of such a pair.
  • a further three leg node 160C and 160E Part way along each of the two long sides of the cell is a further three leg node 160C and 160E.
  • the left hand (in the drawing) wall of the cell above node 160E is stepped axially to the left at node 160E, but the right hand wall does not do so until node 160C.
  • the portion 170H corresponds to a "hole" 118.
  • the stent strut matrix designs of the present invention lend themselves to covered stent embodiments, such as stent grafts.
  • the "holes" 118 can offer good possibilities for bonding together, across the stent wall, films or membranes ⁇ such as of expanded PTFE) that lie radially within and outside the stent annulus .
  • the state of the art is replete with teachings how to apply coatings to stents but a stent matrix in accordance with this invention offers possibilities not available with prior art stent strut matrices .
  • the layout of struts in the real life expanded configuration ⁇ can be managed by somehow restraining the struts on a jig, in the layout desired, during heat-setting of the stent shape which is to be "remembered” by its shape memory alloy. This can be done, for example, by heat-setting the stent matrix on a mandrel which has been engraved with the desired stent pattern.
  • the struts are accommodated in the troughs of the engraving, during the heat-setting step.
  • a helical stent like a spiral wire that "unwinds" when placed in a bodily lumen (the original "Dotter” prosthesis) can be represented by the symbol for a “bishop” chess piece, that moves sideways as much as it moves up and down the chessboard, but always in a straight line.
  • the "knight” chess piece follows a distinctive path that can be characterised as “two steps forward and one step across” (the knight has other possibilities such as “two steps across followed by one step backwards” but for the purposes of the present description we need not concern our with these other possibilities.
  • the present invention seeks to take the best of both the ring stent and the spiral stent, and to do this by building stenting loops that, in one sense, advance around the circumference in a direction perpendicular to the stent axis while, in another sense, spiralling around the lumen.
  • the zig-zag loops can advance for a circumferential portion perpendicular to the axis and then step axially sideways, before resuming their advance, for another small portion of the circumference, perpendicular to the longitudinal axis of the annulus . See Figs. 5 and 6.
  • stents according to the present invention offer the possibility of achieving, simultaneously, both a high radial stenting force and a high tolerance of bending after placement in the body.
  • the zig-zag struts may include a repeating pattern made of an unit of four generally linear members that extend oblique to the longitudinal axis to intersect each other at three apices spaced apart circumferentially and axially.
  • the prosthesis can utilize not only the circumferential bridges but also other bridge configurations in combination.
  • the bridge directly connects a peak of one circumferential section to another peak of an adjacent circumferential section.
  • the bridge may connect a peak of one circumferential section to a trough of an adjacent circumferential section.
  • the bridge can connect a trough of one circumferential section to a trough of an adjacent circumferential section.
  • the undulations can be wave-like in pattern.
  • the wave-like pattern can also be generally sinusoidal in that the pattern may have the general form of a sine wave, whether or not such wave can be defined by a mathematical function.
  • any wave-like forms can be employed so long as it has amplitude and displacement.
  • the term "implantable prosthesis" is intended to cover not only a bare stent but also coated, covered, encapsulated, bio-resorbable stent or any portion of similar stents .
  • Bio-active agents can be added to the prosthesis (e.g., either by a coating or via a carrier medium such as resorbable polymers) for delivery to the holt's vessel or duct.
  • the bio-active agents may also be used to coat the entire stent.
  • a material forming the stent or coupled to the stent may include one or more (a) non-genetic therapeutic agents, (b) genetic materials, (c) cells and combinations thereof with (d) other polymeric materials.
  • Non-genetic therapeutic agents include anti- thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone) ; anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiproliferative/anti-miotic agents such, as paclitaxel, 5-fluorouracil , cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; anesthetic agents such as
  • Genetic materials include anti-sense DNA and RNA, DNA coding for, anti-sense RNA, tRNA or rRNA to replace defective or deficient endogenous molecules, angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor epidermal growth factor, transforming growth factor alpha and beta, platelet-derived endothelial growth factor, platelet- derived growth factor, tumor necrosis factor alpha, hepatocyte growth factor and insulin like growth factor, cell cycle inhibitors including CD inhibitors, thymidine kinase
  • BMP's bone morphogenic proteins
  • BMP's BlVfiP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-I), BMP-8, BMP-9, BMP-IO, BMP-I, BMP-12, BMP-13, BMP-14, BMP-I5, and BMP-16.
  • Desirable BMP ' s are any of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 and BMP-7.
  • These dimeric proteins can be provided as homodimers, heterodimers , or combinations thereof, alone or together with other molecules.
  • molecules capable of inducing an upstream or downstream effect of a BMP can be provided.
  • Such molecules include any of the "hedgehog" proteins, or the DNA's encoding them.
  • Cells can be of human origin (autologous or allogeneic) or from an animal source (xenogeneic) , genetically engineered if desired to deliver proteins of interest at the deployment site.
  • the cells may be provided in a delivery media.
  • the delivery media may be formulated as needed to maintain cell function and viability.
  • Suitable polymer materials as a coating or the base material may include polycarboxylic acids, cellulosic polymers, including cellulose acetate and cellulose nitrate, gelatin, polyvinylpyrrolidone, cross-linked polyvinylpyrrolidone, polyanhydrides including maleic anhydride polymers, polyamides, polyvinyl alcohols, copolymers of vinyl monomers such as EVA, polyvinyl ethers, polyvinyl aromatics, polyethylene oxides, glycosaminoglycans , polysaccharides, polyesters including polyethylene terephthalate, polyacrylamides, polyethers, polyether sulfone, polycarbonate, polyalkylenes including polypropylene, polyethylene and high molecular weight polyethylene, halogenated polyalkylenes including polytetrafluoroethylene, polyurethanes , polyorthoesters , proteins, polypeptides, silicones, siloxane polymers, polylactic acid
  • Polyacrylic acid available as HYDROPLUS ® (Boston Scientific Corporation, Natick, Mass.), and described in U.S. Pat. No. 5,091,205, the disclosure of which is hereby incorporated herein by reference, is particularly desirable. Even more desirable is a copolymer of polylactic acid and polycaprolactone .

Abstract

An annular mesh expandable radially from a compact diameter to a radially- expanded deployed disposition in which the mesh is capable of sustaining a radially outwardly directed resistive force even when flexing its longitudinal axis out of a straight line, the mesh being composed of stenting struts, the stenting struts being arranged in a plurality of zig-zag strings around the circumference of the lumen, with occasional connector struts joining adjacent strings to create a closed circumference unit cell between two such connector struts and two adjacent connected strings there being a plurality of such unit cells arranged in sequence around the circumference between said two adjacent strings; and characterised in that there is a non-constant increment of strut length, serving to displace along the longitudinal axis each unit cell relative to the circumf erentially next adjacent unit cell.

Description

Annular Mesh
Field of, , the Invention
This invention relates to an annular mesh that defines a lumen that surrounds a longitudinal axis of the mesh, the mesh being capable of sustaining a radially outwardly- directed resistive force even while flexing in response to externally applied forces that bend its longitudinal axis out of a straight line, the mesh being composed of struts, the struts defining a plurality of repeating unit cells each with a closed periphery, a string of said unit cells providing each of a plurality of stenting loops that surround said lumen .
Background Art
Such an annular mesh is the operative part of a bodily prosthesis that is commonly known as a stent. The purpose of the stent is to maintain a bodily lumen patent and, to do this, the mesh of the stent must resist the radially inward pressure of the bodily tissue that would otherwise close the bodily lumen.
As usage of annular mesh stents becomes ever more sophisticated, the demands for the annular mesh to be flexible, even while it resists radially inward pressure from bodily tissue, also increase. Stent designers have found it difficult to increase flexibility (in response to requirements for the longitudinal axis of the mesh to bend out of a straight line) while retaining adequate resistance to radially inward forces on the mesh.
Readers will readily appreciate that improvements in stent design could yield annular meshes that are interesting for application beyond bodily prostheses, whenever a combination of good resistance to radially inward force, and good bending flexibility, is required. The present invention may have applications beyond bodily prostheses and therefore the definition of the present invention refrains from limitation to stents.
Up to now, there have been two archetypal stent mesh designs, the first exhibiting a sequence of stenting rings each of which is a closed loop around the longitudinal axis. Adjacent stenting rings need to be connected so as to maintain a predetermined spacing between adjacent stenting rings along the length of the stent. Individual stenting rings have little or no capacity to bend when the longitudinal axis of the annular mesh is urged by external forces into a bent rather than a straight line, so the connectors between adjacent stenting rings carry most of the strain that allows such bending. Increasing the number of connectors increases the rigidity of the mesh, but an insufficient number of connectors can prejudice the integrity of the mesh. In consequence, many of the connectors evident in commercial stents are long and serpentine rather than short and straight. For examples of ring stents, see for example US-B- 6770089, US2002/0116051 and WO publications 2005/067816, 96/26689, 99/55253 and 03/055414.
The other characteristic form of a stent mesh is the helical stent, in which stenting struts proceed as zig zags around a spiral path from one end of the stent to the other. Connectors may be provided at spaced intervals, between successive turns of the spiral, for locational integrity of the mesh. A spiral form mesh has inherently more flexibility, and less resistance to radially inwardly directed forces, than is the case with a stack of closed stenting loops arranged transverse to the longitudinal axis of the annulus of the stent. For examples of helical stents, see for example, EP-A-1245203 and 870483, US Patents 6053940 and WO publications 2002/049544 and 01/01889. Considering both the "ring stent" and "helical stent" categories, stenting loops advance around the circumference of the stent lumen as a zig-zag of stent struts that alternate with zones of inflection. Taking the line that is the bisector of the angle between two adjacent struts of a zig-zag loop, that bisector will likely lie parallel or near parallel to the longitudinal axis of the stent lumen, in any ring stent. Conversely, in any helical stent, that bisector will likely lie at an angle to the longitudinal axis, that is larger as the helical pitch of the stenting loops gets larger.
Summary of the Invention
The present inventor recognized the advantages in retaining something of the flexibility of the spiral stent mesh, together with something of the radial force capability of closed stenting loops . This he accomplishes by providing a unit cell for the stent matrix, which resembles that of a ring stent yet, when assembled into the stent matrix, yields a spiral wind of unit cells around the longitudinal axis of the stent .
The point can be illustrated by a chessboard. A ring stent is like a rook (castle) . The zig-zag stenting ring advances around the circumference strictly perpendicular to the longitudinal axis of the stent lumen. A helical stent is like the bishop. He advances in a straight line again, but slanting to the long axis of the lumen. Embodiments of the present invention exhibit a path of advance of the zig-zag stenting loops like the way the knight moves - forwards, then across, then forwards again,
In one embodiment of annular mesh in accordance with the present invention, successive stenting loops are joined end- to-end in a continuous spiral around the longitudinal axis of the annulus , but the successive turns of the spiral are made out of a plurality of unit cells, each with a closed periphery. The closed cells contribute a greater capability than a pure spiral stent to resist externally imposed radially inwardly directed forces, while the spiral architecture of the mesh contributes more flexibility than a closed loop stent mesh. Not all struts that make up the periphery of the unit cell share the same length. By introducing a strut length increment within the periphery, the invention can be realised.
Thinking about conventional ring stents, typically all struts in a unit cell have the same length. As for conventional spiral stents, the struts typically exhibit a constant incremental shift of the position of the struts along the longitudinal axis of the stent. In the present invention, the periphery of the unit cell is characterised by a departure form this degree of uniformity.
Typically, in an annular mesh in accordance with the present invention, there is a strut that is shared by two adjacent unit cells, that strut contributing to the periphery of both of the two adjacent cells. In one embodiment, each such strut has a length direction that is parallel to the longitudinal axis. In other embodiments, the length direction of the strut is not parallel to the longitudinal axis.
Looking at the unit cells of prior art closed loop stenting meshes, it is often possible to identify a unit cell that exhibits mirror symmetry about a plane that includes the longitudinal axis of the mesh. Typically, in the present invention, the unit cell lacks such mirror symmetry. Instead, the unit cell of the present invention typically exhibits 180° rotational symmetry about a rotational axis that is perpendicular to the longitudinal axis of the annular mesh and also intersects the longitudinal axis of the annulus. In stent strut matrices, simplicity is a desirable objective. If only for this reason, stent unit cells with 180° rotational symmetry are preferred.
Below is a detailed description of individual embodiments, which helps to make this more clear.
The mesh of the present invention finds particular application in a stent for transluminal implantation in a body, and that stent may be, for example, a self-expanding stent or a balloon expansible stent . Conveniently, the annular mesh is formed from a sheet-form workpiece and, although that workpiece could be a flat sheet, it is desirably in the form of a seamless tube. The art of creating a stent mesh by cutting slits in a workpiece is by now quite well known. Typically, a computer-controlled laser is employed to cut slits in a seamless tubular workpiece held on a jig and, typically, the slits are parallel to the long axis of the workpiece.
While an annular mesh in accordance with the present invention typically displays a single spiral of the unit cells, that exhibits a pitch that corresponds to the length of the unit cell in the longitudinal axis direction of the annulus , this need not be so. One envisages meshes that exhibit a double spiral, but this is unlikely to be preferred, because of the constraints which such a design imposes on the dimensions of the unit cell.
Desirably, the spiral pattern mesh will exhibit connectors regularly arranged around the circumference of the annulus with the view to maintaining desired axial spacing between successive adjacent turns of the spiral. Preferably, these connectors are staggered circumferentially with respect to the connectors joining the next adjacent pair of stenting loops around the annulus, for optimising the balance between flexibility and structural integrity. With the inherent flexibility of a spiral pattern, one envisages the possibility of using simple straight struts as connectors, and not needing to resort to the lengthy or serpentine connectors often found in prior art stent meshes . Simplicity of design is always an advantage, and stent architecture is no exception.
One way of recognising the hybrid nature of the stents according to the present invention is to contemplate the orientation of the bisector of the angle between the struts that form any one zig-zag of the mesh. It will tend to be parallel or near parallel to the longitudinal axis of the stent lumen, more like a ring stent than a helical stent. Yet, overall, the mesh of the present stents is recognisably a helical pattern rather than a stack of closed stenting loops .
The inherent flexibility and radial strength of the annular mesh of the present invention will be useful not only for bare stents but also for the stent meshes used in grafts, or other annular meshes used in surgical tools such as vascular filters, in which the mesh would be used to carry a filter membrane .
For a better understanding of the present invention and to show more clearly how the same may be carried into effect, reference will now be made, by way of example, to the accompanying drawings . These are incorporated herein and constitute part of this specification. They illustrate presently preferred embodiments of the invention and, together with the general description above, and the detailed description below, serve to explain the features of the invention .
Brief Description of the Drawings
Figs. 1 to 4 each show a view of an annular mesh, opened out flat in a radially expanded configuration; Fig. 5 shows a fragment of a laser cutting pattern on a tubular workpiece laid out flat;
Fig. 6 shows at smaller scale the complete workpiece of Fig. 5;
Fig. 7 is a photograph of part of the Fig. 6 workpiece after radial expansion;
Fig. 8 is a schematic representation of the strut pattern of Fig 7; and
Fig. 9 is a diagram of the way three chess pieces more over a chessboard.
Detailed Description
It is convenient, for two dimensional drawing sheets, representing an annular mesh matrix, to open the matrix out and lay it flat on the plane of the drawing sheet. This has been done, in each of the accompanying drawing Figures 1 to 4, 5, 6 and 8. The skilled reader will appreciate that each of drawing Figures 1 to 4, 5, 7 and 8 shows only a representative portion of the annular mesh, enough to reveal the characteristic repeating unit cell so that the reader can complete the rest of the annular rnesh . In each case, the longitudinal axis of the annular mesh extends horizontally across the drawing page. Thus, for investigation of mirror symmetry of one of the unit cells displayed in any of the attached drawing sheet, one considers symmetry across a plane that extends perpendicular to the plane of the page, and lies in the East-West direction. For rotational symmetry, the relevant rotational axis is one that extends perpendicularly upwards out of the plane of the drawing page. After having considered the drawings, and the identification of the respective unit cell, the reader will be able to determine and confirm that none of the illustrated unit cells displays symmetry across a mirror plane as thus defined but all of the unit cells display 180° rotational symmetry about a rotational axis extending perpendicularly upwards from the plane of the drawing.
Looking first at drawing Figure 1, we can ascertain in the drawing a portion of the mesh that includes four slanting zig-zag strings of stenting struts, marked A, B, C and D. The repeating unit cell is marked Ul and there are two such unit cells needed to make up one complete turn around the circumference of the annulus . The zig-zag strings A and B are bridged by only two connector struts 10 and 12, it being appreciated that strut 12 between strings A and B at the foot of the page is the same as strut 16 between strings C and D at the top of the page of drawing Fig. 1 connecting zig-zag strings C and D. Likewise, zig-zag strings C and D are connected by only two struts 14 and 16.
The connector struts 18 and 20 that connect zig-zag strings B and C are circumferentially staggered relative to the struts 10, 12, 14 and 16 that make up parts of the periphery of the unit cells in the next adjacent stenting loops, formed by strings A and B and strings C and D respectively. There are two unit cells Ul lying between zig-zag string B and zig-zag string C. One of those unit cells is evident, in full, in Fig. 1. The other is just as much a closed periphery cell, even though in Fig. 1 it appears in two separate halves, both with an incomplete periphery, and marked U2t at the top of the page and U2b at the bottom of the page. In other words U2t + U2b = Ul.
The drawing shows the annulus in a radially expanded disposition, ready to resist radially inwardly directed forces tending to reduce the diameter of the lumen surrounded by the annular mesh. Supposing that the mesh is representative of the strut matrix of a transluminally delivered stent, one can imagine the disposition of the struts shown in Fig. 1 when the strut is in a radially small transluminal delivery disposition, by compressing the strut arrangement presented in Fig. 1, in a North-South direction on the drawing page (supposing North is at the top of the page) . The skilled reader will appreciate that all of the struts concertina or fold down to a disposition in which they are lying more or less horizontally, East-West, on the drawing page. One can further imagine how such a strut matrix can be made from a seamless tubular workpiece, by laser cutting slits in the workpiece, to leave struts having the wall thickness of the annular workpiece, all such slits, and all such struts, having a length direction parallel to the East-West longitudinal axis of the annular mesh shown in the drawing .
It will be evident that the design shown in Fig. 1 is of unit cells with shared boundaries, obviating the need for any connector struts between adjacent unit cells that do not themselves constitute a part of the closed periphery of one or other unit cell of the matrix. One can imagine struts 18 an 20 as connectors, connecting like unit cells lying between zig-zag strings A and B with end cells located between zigzag strings A and B. However, struts 18 and 20 are themselves part of the closed periphery of unit cells of the same form, lying between zig-zag strings B and C.
Also evident from Fig. 1 is that not all the stenting struts in each zig-zag string A, B, C, D have the same length. Struts such as strut 22 are notably short. In each unit cell Ul, we can discern two of the short struts 22. Rotating the unit cell by 180° about a rotational axis perpendicular to the plane of the page will bring each of the two short struts to the location of the other of the two short struts in any of the unit cells. Turning to Fig. 2, presented is a unit cell that exhibits around its periphery a larger number of struts than is evident from the unit cell of Fig. 1. In Fig. 2, a string of only three unit cells is needed to complete a circumference of the annulus of the raesh. It will again be appreciated that unit cell U3 has 180° rotational symmetry but not mirror plane symmetry. Imagining the mesh compressed in the North- South direction on the page, one can appreciate that, in the radially compressed disposition of the mesh, all slits and all struts extend East-West on the page, parallel to the longitudinal axis of the annulus.
The design of Fig. 3 differs from the designs of Fig. 1 and Fig. 2 in that the adjacent loops of unit cells U4 are spaced from each other longitudinally (East-West in the drawing) but joined to each other longitudinally by connector struts 40, of which there are four, spaced by equal intervals around the circumference of the annulus. Compared to the unit cell Ul of Fig. 1, each unit cell U4 has around its periphery four more stenting struts, two in each zig-zag string. This extra zigzag in the circumferential length (North-South in the drawing) of each unit cell U4 provides the scope for placing connector struts 40 at locations intermediate the circumferential end struts 42, 44 of each of the unit cells. Interesting is that the cells of each stenting loop of four unit cells U4 are not circumferentially staggered relative to the cells of the axially next adjacent string of unit cells U4. However, lying axially between the two shown strings of unit cells U4 is a string of 4 unit cells U5 that are alike with each other but different from the unit cell U4.
The view from any unit cell U4, looking along the longitudinal axis of the annulus, is of other unit cells U4 , located (in the drawing) due East and due West of the viewing position, without any circumferential stagger towards the North or the South. Nevertheless, by virtue of the different length struts, any particular peak point of inflection 46 faces in the longitudinal direction of the annulus a valley 48 between two struts 50 and 52 of the next adjacent unit cell linked by the connector strut 40. Thus, the arrangement of unit cells and connector struts is relatively simple {all struts are cut straight) yet the "peak-to-valley" configuration in the radially expanded disposition shown in Fig. 3 has the merit that flexing of the annular mesh, when the longitudinal axis is bent out of a straight line, does not have the tendency to bring peaks like peak 46 into face- to-face contact with equivalent peaks on a next adjacent stenting loop but, rather tends to bring them down into a valley such as valley 48. Such a configuration is particularly attractive to have, on the inside of the bend, when the annular mesh is being deformed around a tight radius .
It will also be appreciated by skilled readers that although struts 40 are on a line that slants relative to the longitudinal axis of the annulus, when the mesh is in the expanded disposition as shown in Fig. 3, that same strut 40, in the radially compact disposition of the mesh will be parallel to the longitudinal axis. Again, the mesh of Fig. 3 is one that can be made from a seamless tubular workpiece by cutting slits all parallel to the long axis of the tube, to create struts all parallel to the long axis of the tube, which only depart from such a parallel (East-West in Fig. 3} direction, when the mesh is radially expanded up into the opened out zig-zag configuration to be seen from Fig. 3. Again, this is a win for simplicity, this time in the slit- and strut-cutting part of the manufacturing process.
Finally, the unit cell of Fig. 4, U6 is not unlike the one presented in Fig. 2. The most evident difference is the orientation of the strut 50 that is shared between two adjacent unit cells of the stenting loop. Although the connector strut 50 is slanting to the long axis of the annulus when viewed in the expanded configuration of Fig. 4, once again, concertina compression North-South of the mesh of Fig. 4 down to the radially compact disposition in which an annular workpiece can be slitted to provide the strut seen in Fig. 4 will bring strut 50 into an orientation in which it is parallel to the East-West longitudinal axis of the annulus of the Fig. 4 mesh.
It will be appreciated that the unit cells of Figs, 2 and 4 share with those of Fig. 1 the characteristic that the peripheral stenting struts of each unit cell (except connector strut 50), are shared with the adjacent unit cell lying respectively East and West of the unit cell seen in Fig. 4, that is, next adjacent in the longitudinal direction of the annulus of the mesh. Struts 50 are connectors, but also struts contributing to the closed periphery of a unit cell U5. There are no connectors in the annular meshes of any of Figs. 1, 2 and 4 which are not also struts that are part of the periphery and closed circumference of a unit cell of the matrix.
Although the various unit cells of Figs. 1-4 have been described individually, it is intended that various combinations of the respective unit cells of Figs. 1-4 be utilized for a stent framework. For example, a stent framework can e constructed, in sequence, unit cells of Figure 1 connected to the unit cells of Figure 2, which are connected to the unit cells of Figure 3, which are also connected to the unit cells of Figure 4, i.e., Figl-Fig4- Fig2-Fig3, Fig4-Figl-Fig2-Fig3 and so on in at least 24 different permutations.
Attention is now directed to drawing Figs. 5 to 8. Fig. 6 shows a stent matrix from one end to the other, laid out flat. Fig. 5 shows a middle portion of the length of the Fig. 6 stent matrix. Thus, features of the repeating stenting strut matrix will be described by reference to Fig. 5, where the dimensions are bigger, whereas features visible only at the ends of the stent matrix will be described by reference to Fig. 6.
Looking at Fig. 5, we see a multitude of slits that are linear and parallel to the longitudinal axis of the stent lumen, each stenting strut having a constant width in the circumferential direction of the matrix. For clarity, only one of the struts 110 has a lead line and reference number, only one of the laser cut slits 112 and in only one location, reference W, the characteristic circumferential width of the stenting strut as indicated.
Overall, the matrix displays a slanting or helical pattern, in that each sequence of stenting struts alternating with points of inflection 114, is seen to lie between notional slanting lines Sl and S2 that lie at an acute angle to the longitudinal axis of the matrix. By contrast, a so-called "ring stent" would display stenting rings between two notional lines that are perpendicular to the longitudinal axis of the stent.
Each of the inclined zig-zag stenting loops is joined to the adjacent stenting loop by connector struts 116 that are seen to have a circumferential width of 2W and that extend across the slanting lines Sl and S2 with a length direction parallel to the long axis of the stent. As can be see, there are four such connector struts 116 in each turn of the stenting loop around the axis of the matrix. It is part of the advantage of the invention that it can yield stents with a high flexibility even through stenting loops are connected by a plurality of simple short straight axial connectors.
It can also be seen that there are "holes" 118 in the matrix, that is, through apertures in the stent wall, of substantial open area, even in the as cut matrix, which holes also span the slant line Sl, S2 and lie between two adjacent stenting loops. These holes 118 arise during the laser cutting of the stent matrix, after the laser has cut all around the periphery of hole 118. See our own earlier WO 2001/032102 for a description of the creation of similar holes.
Importantly, each stenting loop 120 that lies between two slanting lines, for example Sl and S2 , exhibits loop portions with a constant length of laser cut 112 and stenting strut 110. Furthermore, these cuts, struts and points of inflection 114 present an appearance of part of a ring stent with its stenting loops perpendicular to the long axis of the stent. They are interspersed by occasional, shorter than usual struts 122 that are contiguous with a connector strut 116. The skilled reader will appreciate that the response of a strut to any particular applied bending stress depends on the length of that strut.
Before leaving Fig. 5 it is important to note that every point of inflection 114 is facing "head-on" a point of inflection of the next adjacent stenting loop, either across a gap 118 or indeed "nose-to-nose" as at 124.
Moving to Fig. 6, we see in particular an architecture at each end of the stent, between the slanting architecture of the main length of the stent and the end stenting rings 130, one at each end of the stent. Connecting the slanting architecture to the perpendicular end ring are four connector struts distributed evenly around the circumference of the lumen, but these four struts, 132, 134, 136 and 138 are of different lengths and widths. The reader will appreciate that the meeting of a spiral pattern and a perpendicular end ring is necessarily going to give rise to "holes" between the slanting and perpendicular architecture that are unsymmetrical . The holes in the present case are referenced 140, 142, 144 and 146. Hole 140, in particular, is relatively large in the axial direction. Turning now to drawing Figures 7 and 8, we see the Fig. 5 and 6 matrix in expanded disposition, as it would be when working to hold radially open a bodily lumen. Fig. 7 is useful because it is a photomicrograph of a real embodiment, so that it gives an impression of the way in which shorter struts bend less than longer ones. Fig. 8 is schematic and does not show this reality. Its suggestion that every strut is inclined at the same constant angle to the longitudinal axis of the stent lumen, in the expanded configuration, is not the reality. Neither does Fig.8 preserve the relative scale of the length difference between the regular strut length 110 and the occasional "special" strut length 122. In reality, as seen in Fig. 7 and Figs. 5 and 6, the occasional short strut is nearly as long as the normal strut 110. However, Fig. 8 is useful in showing how points of inflection 114 no longer face each other head on, across a short axial gap. At those locations where the points of inflection would be "nose-to- nose" especially on the inside of a bend when the stent is bent into a banana shape, as might happen in normal use in peripheral vascular applications, we see the points of inflection to be circumferentially staggered relative to each other so that there is a minimal risk of them impacting nose- to-nose, on the inside of the bend, in use of the stent.
Notably, the presence of distinct "holes" 118, in Figs. 5 and
6 is no longer apparent in the stenting disposition of Figs.
7 and 8. Instead, these zig-zag strut patterns give every appearance of providing uniform cover for the entirety of the bodily lumen to be stented, without any longer any "holes" through which bodily tissue can easily pass.
It should also be noted that the huge increase in circumferential length, on moving from the as cut configuration of Fig. 5 to the working disposition of Figs. 7 and 8 has the effect of bringing the slant angle (Sl, S2) back much closer to perpendicular to the long axis of the lumen. Whereas the cut pattern of Fig. 5 looks strikingly helical, the strut pattern being displayed in Figs. 7 and 8 looks much closer to that of a ring stent with axially spaced, discrete, endless stenting loops. It will appreciated that the greatest radial force that can be generated by a particular stent architecture is when the zig-zag loops are arranged in endless loops, discrete, and in a stack spaced along the axis of the stent. Fig. 7 is quite a close approximation to this ideal.
Figure 8 serves another useful purpose, to render more easily visible the hybrid (intermediate between "ring" and "spiral" stent) nature of the embodiment.
We see in the strut matrix a plurality of nodes 160, where three struts end, one of which is a connector strut 116. In this embodiment each node 160 is also a point of inflection 114 between a regular stenting strut 110 and one of the occasional shorter struts 122.
Let us examine the zig-zag string of stenting struts that includes the three leg nodes 160A, B, C and D. Each portion of the zig-zag string, between any two adjacent nodes A-B, B- C, C-D, is a portion of a stenting ring that is orientated perpendicular to the stent axis. Each circumferential portion A to B, B to C, C to D is axially stepwise offset from its neighbour portions, the step occurring at the three leg node. The same can be discerned in the other drawing figures but the schematic representation of Fig. 8 makes it a little easier to recognise. Making, in Fig. 8, the short struts 122 exaggeratedly shorter also helps to reveal the effect.
Looking at Fig. 8 and concentrating on a unit cell with a circumference that displays 6 three leg nodes, one can recognise two pairs of nodes defining the corners of the unit cell at each circumferential end of the cell. In unit cell 170, for example, nodes 160B and 160D are each a member of such a pair. Part way along each of the two long sides of the cell is a further three leg node 160C and 160E. In the middle portion of 170H of the length of the unit cell 170, the left hand (in the drawing) wall of the cell above node 160E is stepped axially to the left at node 160E, but the right hand wall does not do so until node 160C. Thus, the portion 170H corresponds to a "hole" 118. But it does not look much like a "hole" in the "real life" photograph of Fig. 7 because the differential bending performance of the different length struts are compensating for the effect, and thereby tending to "fill" the hole with stent strut zig-zag portions. This is an incidence of serendipity, a happy unanticipated coincidence which enhances the performance of the design.
The stent strut matrix designs of the present invention lend themselves to covered stent embodiments, such as stent grafts. The "holes" 118 can offer good possibilities for bonding together, across the stent wall, films or membranes {such as of expanded PTFE) that lie radially within and outside the stent annulus . The state of the art is replete with teachings how to apply coatings to stents but a stent matrix in accordance with this invention offers possibilities not available with prior art stent strut matrices .
The layout of struts in the real life expanded configuration {such as shown in Fig. 7) can be managed by somehow restraining the struts on a jig, in the layout desired, during heat-setting of the stent shape which is to be "remembered" by its shape memory alloy. This can be done, for example, by heat-setting the stent matrix on a mandrel which has been engraved with the desired stent pattern. The struts are accommodated in the troughs of the engraving, during the heat-setting step.
Finally we turn to Fig. 9 of the drawings, and the reference earlier in this description to the way in which pieces move on a chessboard. Looking at the diagram of Fig. 9, length along the stent lumen is indicated by the X-axis L, whereas movement around the circumference of the stent lumen is indicated by progress along the Y-axis marked C. For a ring stent we use the symbol for the chess piece called the "rook" or "castle" and this of course is a line that is perpendicular to the long axis of the stent and that extends simply all the way around the circumference. Likewise, a helical stent, like a spiral wire that "unwinds" when placed in a bodily lumen (the original "Dotter" prosthesis) can be represented by the symbol for a "bishop" chess piece, that moves sideways as much as it moves up and down the chessboard, but always in a straight line.
By contrast, the "knight" chess piece follows a distinctive path that can be characterised as "two steps forward and one step across" (the knight has other possibilities such as "two steps across followed by one step backwards" but for the purposes of the present description we need not concern ourselves with these other possibilities. Important to stress is that the present invention seeks to take the best of both the ring stent and the spiral stent, and to do this by building stenting loops that, in one sense, advance around the circumference in a direction perpendicular to the stent axis while, in another sense, spiralling around the lumen. To do this, the zig-zag loops can advance for a circumferential portion perpendicular to the axis and then step axially sideways, before resuming their advance, for another small portion of the circumference, perpendicular to the longitudinal axis of the annulus . See Figs. 5 and 6.
The aim to achieve the "best of both worlds" is of course to achieve the radial force of a ring stent with the flexibility of a spiral stent. Intuitively, one can see from Fig. 7 that the embodiments of the present invention probably do provide a high proportion of the stenting force of a ring stent. When it comes to flexibility, one can also intuitively see from Figs . 7 and 8 that bending the stent into a banana shape is probably going to be achievable without too much local overstressing of the material of the stent, even to the extent of allowing points of inflection of the zig-zag stenting rings to pass by each other as they enter the substantially triangular spaces available between two struts of the adjacent stenting ring, the impact of points of inflection, nose-to-nose being generally avoided.
In this way, stents according to the present invention offer the possibility of achieving, simultaneously, both a high radial stenting force and a high tolerance of bending after placement in the body.
Where undulations are embodied in the form of zig-zag struts, the zig-zag struts may include a repeating pattern made of an unit of four generally linear members that extend oblique to the longitudinal axis to intersect each other at three apices spaced apart circumferentially and axially. Also, the prosthesis can utilize not only the circumferential bridges but also other bridge configurations in combination. Alternatively, the bridge directly connects a peak of one circumferential section to another peak of an adjacent circumferential section. In yet another alternative, the bridge may connect a peak of one circumferential section to a trough of an adjacent circumferential section. In a further alternative, the bridge can connect a trough of one circumferential section to a trough of an adjacent circumferential section. Moreover, the undulations can be wave-like in pattern. The wave-like pattern can also be generally sinusoidal in that the pattern may have the general form of a sine wave, whether or not such wave can be defined by a mathematical function. Alternatively, any wave-like forms can be employed so long as it has amplitude and displacement. For example, a square wave, saw tooth wave, or any applicable wave-like pattern defined by the struts where the struts have substantially equal lengths or unequal lengths. And as used herein, the term "implantable prosthesis" is intended to cover not only a bare stent but also coated, covered, encapsulated, bio-resorbable stent or any portion of similar stents .
Bio-active agents can be added to the prosthesis (e.g., either by a coating or via a carrier medium such as resorbable polymers) for delivery to the holt's vessel or duct. The bio-active agents may also be used to coat the entire stent. A material forming the stent or coupled to the stent may include one or more (a) non-genetic therapeutic agents, (b) genetic materials, (c) cells and combinations thereof with (d) other polymeric materials.
(a) Non-genetic therapeutic agents include anti- thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPack (dextrophenylalanine proline arginine chloromethylketone) ; anti-proliferative agents such as enoxaprin, angiopeptin, or monoclonal antibodies capable of blocking smooth muscle cell proliferation, hirudin, and acetylsalicylic acid; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, and mesalamine; antineoplastic/antiproliferative/anti-miotic agents such, as paclitaxel, 5-fluorouracil , cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; anti-coagulants, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet peptides; vascular cell growth promotors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional activators, and translational promotors; vascular cell growth inhibitors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; cholesterol-lowering agents; vasodilating agents; and agents which interfere with endogenous vascoactive mechanisms.
(b) Genetic materials include anti-sense DNA and RNA, DNA coding for, anti-sense RNA, tRNA or rRNA to replace defective or deficient endogenous molecules, angiogenic factors including growth factors such as acidic and basic fibroblast growth factors, vascular endothelial growth factor epidermal growth factor, transforming growth factor alpha and beta, platelet-derived endothelial growth factor, platelet- derived growth factor, tumor necrosis factor alpha, hepatocyte growth factor and insulin like growth factor, cell cycle inhibitors including CD inhibitors, thymidine kinase
{ "1XK" } and other agents useful for interfering with cell proliferation the family of bone morphogenic proteins ("BMP's"} , BlVfiP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-I), BMP-8, BMP-9, BMP-IO, BMP-I, BMP-12, BMP-13, BMP-14, BMP-I5, and BMP-16. Desirable BMP ' s are any of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 and BMP-7. These dimeric proteins can be provided as homodimers, heterodimers , or combinations thereof, alone or together with other molecules. Alternatively or, in addition, molecules capable of inducing an upstream or downstream effect of a BMP can be provided. Such molecules include any of the "hedgehog" proteins, or the DNA's encoding them.
(c) Cells can be of human origin (autologous or allogeneic) or from an animal source (xenogeneic) , genetically engineered if desired to deliver proteins of interest at the deployment site. The cells may be provided in a delivery media. The delivery media may be formulated as needed to maintain cell function and viability.
(d) Suitable polymer materials as a coating or the base material may include polycarboxylic acids, cellulosic polymers, including cellulose acetate and cellulose nitrate, gelatin, polyvinylpyrrolidone, cross-linked polyvinylpyrrolidone, polyanhydrides including maleic anhydride polymers, polyamides, polyvinyl alcohols, copolymers of vinyl monomers such as EVA, polyvinyl ethers, polyvinyl aromatics, polyethylene oxides, glycosaminoglycans , polysaccharides, polyesters including polyethylene terephthalate, polyacrylamides, polyethers, polyether sulfone, polycarbonate, polyalkylenes including polypropylene, polyethylene and high molecular weight polyethylene, halogenated polyalkylenes including polytetrafluoroethylene, polyurethanes , polyorthoesters , proteins, polypeptides, silicones, siloxane polymers, polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxybutyrate valerate and blends and copolymers thereof, coatings from polymer dispersions such as polyurethane dispersions (for example, BAYHDROL* fibrin, collagen and derivatives thereof, polysaccharides such as celluloses, starches, dextrans, alginates and derivatives, hyaluronic acid, squalene emulsions. Polyacrylic acid, available as HYDROPLUS® (Boston Scientific Corporation, Natick, Mass.), and described in U.S. Pat. No. 5,091,205, the disclosure of which is hereby incorporated herein by reference, is particularly desirable. Even more desirable is a copolymer of polylactic acid and polycaprolactone .
While the invention has been described in terms of particular variations and illustrative figures, those of ordinary skill in the art will recognize that the invention is not limited to the variations or figures described. In addition, where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art will recognize that the ordering of certain steps may be modified and that such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described- above. Therefore, to the extent there are variations of the invention, which are within the spirit of the disclosure or equivalent to the inventions found in the claims, it is the intent that this patent will cover those variations as well. Finally, all publications and patent applications cited in this specification are herein incorporated by reference in their entirety as if each individual publication or patent application were specifically and individually put forth herein .

Claims

Claims
1. An annular mesh that defines a lumen that surrounds a longitudinal axis of the mesh, the mesh being expandable radially from a compact diameter pre-deployment disposition to a radially expanded deployed disposition in which the mesh is capable of sustaining a radially outwardly directed resistive force even when flexing in response to externally applied forces that bend its longitudinal axis out of a straight line, the mesh being composed of stenting struts, the stenting struts being arranged in a plurality of zig-zag strings around the circumference of the lumen, with occasional connector struts joining adjacent strings of stenting struts thereby to create a closed circumference unit cell between two such connector struts and two adjacent connected strings of stenting struts there being a plurality of such unit cells arranged in sequence around the circumference between said two adjacent strings of stenting struts; and characterised in that: there is a non-constant increment of strut length, within the portion of each of the two said zig-zag string of stenting struts bounding any one said unit cell said non- constant increment serving to displace along the longitudinal axis each unit cell bounded by said zig-zag string relative to the circumferentially next adjacent unit cell bounded by the same zig-zag string.
2. Mesh as claimed in claim 1, which is a stent for a lumen of the human or animal body.
3. Mesh as claimed in claim 1 or 2, wherein the length of the struts of each said zig-zag string portion is constant, except for one strut in each one of the two portions, which is shorter than the other struts of the said portion.
4. Mesh as claimed in claim 1 or 2 , wherein the length of the struts of each said zig-zag string portion is constant, except for two struts in each one of the two portions which are shorter than the other struts of the said portion.
5. Mesh as claimed in claim 1 or 2 , wherein the increment of strut length between any two adjacent struts within each one of the two zig-zag string portions of said unit cell is finite and constant, except for an axial offsetting increment that lies between one and only one adjacent pair of struts of the said one string, which offsetting increment is different from said constant increment.
6. Mesh as claimed in claim 1 or 2 , wherein the increment of strut length between any two adjacent struts within each one of the two zig-zag string portions of each unit cell is finite and constant, except for an axial offsetting increment that lies between two and only two adjacent pairs of struts of the portion, which offsetting increment is different from said constant increment, and not necessarily the same for both of the only two adjacent pairs of struts.
7. Mesh as claimed in any one of the preceding claims, in which the mesh of struts is compatible with manufacture out of a seamless tube, by slitting the tube, through its wall thickness with a multiplicity of slits.
8. Mesh as claimed in claim 7, wherein most or all of the slits are straight.
9. Mesh as claimed in claim 8, wherein the straight slits are parallel to the long axis of the tube.
10. Mesh as claimed in claim 8 or 9 , wherein the connector struts are also formable by slitting the tube.
11. Mesh as claimed In claim 10, wherein connector struts are straight.
12. Mesh as claimed in claim 11, wherein the straight connector struts are parallel to the long axis of the tube.
13. Mesh as claimed in any one of the preceding claims, wherein the zig-zag strings face each other, in the compact pre-deployment disposition peak to peak yet, upon radial expansion to the deployed disposition, these facing peaks of the zig-zag strings move circumferentially away from the facing relationship and into a non-facing (peak-to-valley} relationship thereby enhancing the bending flexibility of the expanded mesh.
14. Mesh as claimed in any one of the preceding claims, wherein each said string of stenting struts exhibits a plurality of circumferentially spaced apart three leg nodes, where a connector strut merges with the zig-zag string, the portion of the zig-zag string between two such nodes being oriented perpendicular to the longitudinal axis, whereby the nodes correspond to steps where the zig-zag strings advance axially along the longitudinal axis.
15. Mesh as claimed in claim 14, wherein the closed circumference of each said unit cell including six said nodes .
16. Mesh as claimed in any one of the preceding claims, wherein the unit cells axially one side of one of the zig-zag strings and the unit cells on the other axial side of the string are alike.
17. Mesh as claimed in any one of claims 1 to 15, wherein the unit cells axially one side of one of the zig-zag strings are of one form, and those on the other side of that zig-zag string are of another form.
18. An annular mesh that defines a lumen that surrounds a longitudinal axis of the mesh, the mesh being expandable radially from a compact diameter pre-deployment disposition to a radially expanded deployed disposition in which the mesh is capable of sustaining a radially outwardly directed resistive force even when flexing in response to externally applied forces that bend its longitudinal axis out of a straight line, the mesh being composed of stenting struts, the stenting struts being arranged in a plurality of zig-zag strings around the circumference of the lumen, with occasional connector struts joining adjacent strings of stenting struts thereby to create a closed circumference unit cell between two such connector struts and two adjacent connected strings of stenting struts there being a plurality of such unit cells arranged in sequence around the circumference between said two adjacent strings of stenting struts; and characterised in that: each zig-zag string of stenting struts advances around the circumference in a pattern which is neither continuously slanting to the longitudinal axis, as the bishop on a chessboard, nor continuously perpendicular to the longitudinal axis, as the rook on a chessboard, but both perpendicular and across, as with the knight on a chessboard.
PCT/EP2007/058912 2006-08-29 2007-08-28 Annular mesh WO2008025762A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/438,527 US9254207B2 (en) 2006-08-29 2007-08-28 Annular mesh
EP07802941A EP2056744B1 (en) 2006-08-29 2007-08-28 Annular mesh
DE602007006026T DE602007006026D1 (en) 2006-08-29 2007-08-28 RINGED NETWORK
CA2690060A CA2690060C (en) 2006-08-29 2007-08-28 Annular mesh
US15/018,568 US9770348B2 (en) 2006-08-29 2016-02-08 Annular mesh

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0616999.9A GB0616999D0 (en) 2006-08-29 2006-08-29 Annular mesh
GB0616999.9 2006-08-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/438,527 A-371-Of-International US9254207B2 (en) 2006-08-29 2007-08-28 Annular mesh
US15/018,568 Continuation US9770348B2 (en) 2006-08-29 2016-02-08 Annular mesh

Publications (1)

Publication Number Publication Date
WO2008025762A1 true WO2008025762A1 (en) 2008-03-06

Family

ID=37102938

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2007/058912 WO2008025762A1 (en) 2006-08-29 2007-08-28 Annular mesh

Country Status (6)

Country Link
US (2) US9254207B2 (en)
EP (1) EP2056744B1 (en)
CA (1) CA2690060C (en)
DE (1) DE602007006026D1 (en)
GB (1) GB0616999D0 (en)
WO (1) WO2008025762A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008119837A2 (en) 2007-04-03 2008-10-09 Angiomed Gmbh & Co. Medizintechnik Kg Bendable stent
WO2010130788A1 (en) * 2009-05-14 2010-11-18 Angiomed Gmbh & Co. Medizintechnik Kg Stent
WO2011034796A1 (en) * 2009-09-18 2011-03-24 Medtronic Vascular Inc. Stent with improved flexibility
US20120029621A1 (en) * 2010-08-02 2012-02-02 Schroeder Valeska Flexible helical stent having intermediate non-helical region
US8152842B2 (en) 2006-08-21 2012-04-10 C. R. Bard, Inc. Self-expanding stent
US8403978B2 (en) 2006-05-17 2013-03-26 C. R. Bard, Inc. Bend-capable tubular prosthesis
US8475520B2 (en) 2006-12-06 2013-07-02 C. R. Bard, Inc. Stenting ring with marker
US8500793B2 (en) 2006-09-07 2013-08-06 C. R. Bard, Inc. Helical implant having different ends
USRE44463E1 (en) 2000-08-18 2013-08-27 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US8551156B2 (en) 2006-11-10 2013-10-08 C. R. Bard, Inc. Stent
US8574286B2 (en) 2006-05-18 2013-11-05 C. R. Bard, Inc. Bend-capable stent prosthesis
US8721709B2 (en) 2007-09-07 2014-05-13 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040267349A1 (en) 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
US8382821B2 (en) 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US9155639B2 (en) * 2009-04-22 2015-10-13 Medinol Ltd. Helical hybrid stent
CN108348345B (en) 2015-06-24 2021-12-28 恩朵罗杰克斯有限责任公司 Endoluminal prosthetic system and method
AU2016401017A1 (en) * 2016-03-31 2018-09-27 Cardinal Health 529, Llc Helical ultra low foreshortening stent
EP3435930B1 (en) 2016-03-31 2022-11-30 Vesper Medical, Inc. Intravascular implants
US10695817B2 (en) 2017-04-24 2020-06-30 Ford Global Technologies, Llc Thirty-six-cornered strengthening member
US20180311926A1 (en) * 2017-04-26 2018-11-01 Ford Global Technologies, Llc Cellular structure
US20180311927A1 (en) * 2017-04-26 2018-11-01 Ford Global Technologies, Llc Cellular structure
US10849769B2 (en) 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US11364134B2 (en) 2018-02-15 2022-06-21 Vesper Medical, Inc. Tapering stent
US10500078B2 (en) 2018-03-09 2019-12-10 Vesper Medical, Inc. Implantable stent

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020116044A1 (en) * 2000-05-22 2002-08-22 Cottone, Robert John Self-expanding stent
US20050182477A1 (en) * 2001-12-20 2005-08-18 White Geoffrey H. Intraluminal stent and graft
US20060030934A1 (en) * 2002-12-24 2006-02-09 Novostent Corporation Vascular prosthesis having improved flexibility and nested cell delivery configuration
WO2007073413A1 (en) * 2005-12-23 2007-06-28 Boston Scientific Limited Stent

Family Cites Families (147)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB453944A (en) 1935-04-10 1936-09-22 John Walter Anderson Improvements in couplings for vehicles
FR2626046A1 (en) 1988-01-18 1989-07-21 Caoutchouc Manuf Plastique Device for joining panels or for producing conduits and its applications
US5091205A (en) 1989-01-17 1992-02-25 Union Carbide Chemicals & Plastics Technology Corporation Hydrophilic lubricious coatings
DE9014230U1 (en) 1990-10-13 1991-11-21 Angiomed Ag, 7500 Karlsruhe, De
US5683448A (en) 1992-02-21 1997-11-04 Boston Scientific Technology, Inc. Intraluminal stent and graft
US5383926A (en) 1992-11-23 1995-01-24 Children's Medical Center Corporation Re-expandable endoprosthesis
ES2166370T3 (en) 1993-01-19 2002-04-16 Schneider Usa Inc IMPLANTABLE FILAMENT IN COMPOSITE MATERIAL.
DE4303181A1 (en) 1993-02-04 1994-08-11 Angiomed Ag Implantable catheter
NL9300500A (en) 1993-03-22 1994-10-17 Industrial Res Bv Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it.
DE69330132T2 (en) 1993-07-23 2001-11-15 Cook Inc FLEXIBLE STENT WITH A CONFIGURATION MOLDED FROM A MATERIAL SHEET
US5527353A (en) 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
DE69510986T2 (en) 1994-04-25 1999-12-02 Advanced Cardiovascular System Radiation-opaque stent markings
JPH07315147A (en) 1994-05-23 1995-12-05 Nishikawa Rubber Co Ltd Attachment structure for drip weather strip
US5636641A (en) 1994-07-25 1997-06-10 Advanced Cardiovascular Systems, Inc. High strength member for intracorporeal use
IL115755A0 (en) 1994-10-27 1996-01-19 Medinol Ltd X-ray visible stent
CA2301351C (en) 1994-11-28 2002-01-22 Advanced Cardiovascular Systems, Inc. Method and apparatus for direct laser cutting of metal stents
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
ATE220308T1 (en) 1995-03-01 2002-07-15 Scimed Life Systems Inc LONGITUDONLY FLEXIBLE AND EXPANDABLE STENT
US6579314B1 (en) 1995-03-10 2003-06-17 C.R. Bard, Inc. Covered stent with encapsulated ends
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
WO1997014375A1 (en) 1995-10-20 1997-04-24 Bandula Wijay Vascular stent
AU690862B2 (en) 1995-12-04 1998-04-30 Target Therapeutics, Inc. Fibered micro vaso-occlusive devices
US5645532A (en) 1996-03-04 1997-07-08 Sil-Med Corporation Radiopaque cuff peritoneal dialysis catheter
US6334871B1 (en) 1996-03-13 2002-01-01 Medtronic, Inc. Radiopaque stent markers
US5824042A (en) 1996-04-05 1998-10-20 Medtronic, Inc. Endoluminal prostheses having position indicating markers
DE19614160A1 (en) 1996-04-10 1997-10-16 Variomed Ag Stent for transluminal implantation in hollow organs
US5855596A (en) 1996-06-25 1999-01-05 International Business Machines Corporation Modular wire band stent
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
US6099561A (en) 1996-10-21 2000-08-08 Inflow Dynamics, Inc. Vascular and endoluminal stents with improved coatings
WO1998020810A1 (en) 1996-11-12 1998-05-22 Medtronic, Inc. Flexible, radially expansible luminal prostheses
DE29621207U1 (en) 1996-12-06 1997-01-30 Roland Man Druckmasch Fastening a heat sink on a printed circuit board
DE19653720A1 (en) 1996-12-10 1998-06-18 Biotronik Mess & Therapieg Stent
IT1291001B1 (en) 1997-01-09 1998-12-14 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT AND ITS PRODUCTION PROCESS
US5858556A (en) 1997-01-21 1999-01-12 Uti Corporation Multilayer composite tubular structure and method of making
US5810872A (en) * 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5902475A (en) 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US5868783A (en) 1997-04-16 1999-02-09 Numed, Inc. Intravascular stent with limited axial shrinkage
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
DE19728337A1 (en) 1997-07-03 1999-01-07 Inst Mikrotechnik Mainz Gmbh Implantable stent
US5824059A (en) 1997-08-05 1998-10-20 Wijay; Bandula Flexible stent
DE69838256T2 (en) 1997-09-24 2008-05-15 Med Institute, Inc., West Lafayette RADIAL EXPANDABLE STENT
US6086611A (en) 1997-09-25 2000-07-11 Ave Connaught Bifurcated stent
US6022374A (en) 1997-12-16 2000-02-08 Cardiovasc, Inc. Expandable stent having radiopaque marker and method
US6503271B2 (en) 1998-01-09 2003-01-07 Cordis Corporation Intravascular device with improved radiopacity
US6113627A (en) 1998-02-03 2000-09-05 Jang; G. David Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
FR2777771B1 (en) 1998-04-27 2000-08-25 Microval TUBULAR AND FLEXIBLE VASCULAR ENDOPROSTHESIS
US6261319B1 (en) 1998-07-08 2001-07-17 Scimed Life Systems, Inc. Stent
US6355057B1 (en) 1999-01-14 2002-03-12 Medtronic, Inc. Staggered endoluminal stent
WO2000049971A1 (en) 1999-02-26 2000-08-31 Advanced Cardiovascular Systems, Inc. Stent with customized flexibility
US7029492B1 (en) 1999-03-05 2006-04-18 Terumo Kabushiki Kaisha Implanting stent and dilating device
DE29904817U1 (en) 1999-03-16 1999-05-27 Amg Handelsgesellschaft Fuer A Blood vessel support device
US6464723B1 (en) 1999-04-22 2002-10-15 Advanced Cardiovascular Systems, Inc. Radiopaque stents
US6551351B2 (en) 1999-07-02 2003-04-22 Scimed Life Systems Spiral wound stent
US6379381B1 (en) 1999-09-03 2002-04-30 Advanced Cardiovascular Systems, Inc. Porous prosthesis and a method of depositing substances into the pores
US6585757B1 (en) 1999-09-15 2003-07-01 Advanced Cardiovascular Systems, Inc. Endovascular stent with radiopaque spine
US6387123B1 (en) 1999-10-13 2002-05-14 Advanced Cardiovascular Systems, Inc. Stent with radiopaque core
DE19952295A1 (en) 1999-10-29 2001-05-23 Angiomed Ag Method of making a stent
US6471721B1 (en) 1999-12-30 2002-10-29 Advanced Cardiovascular Systems, Inc. Vascular stent having increased radiopacity and method for making same
GB0003387D0 (en) 2000-02-14 2000-04-05 Angiomed Ag Stent matrix
GB0009030D0 (en) 2000-04-12 2000-05-31 Angiomed Ag Self-expanding metal stent and method of making it
US20030114918A1 (en) 2000-04-28 2003-06-19 Garrison Michi E. Stent graft assembly and method
DE10026307A1 (en) 2000-05-26 2001-11-29 Variomed Ag Balzers Stent, positioning element and insertion catheter
GB0020491D0 (en) 2000-08-18 2000-10-11 Angiomed Ag Stent with attached element and method of making such a stent
US6699278B2 (en) 2000-09-22 2004-03-02 Cordis Corporation Stent with optimal strength and radiopacity characteristics
US20070276473A1 (en) 2000-09-29 2007-11-29 Llanos Gerard H Medical Devices, Drug Coatings and Methods for Maintaining the Drug Coatings Thereon
US6547818B1 (en) 2000-10-20 2003-04-15 Endotex Interventional Systems, Inc. Selectively thinned coiled-sheet stents and methods for making them
US6758859B1 (en) 2000-10-30 2004-07-06 Kenny L. Dang Increased drug-loading and reduced stress drug delivery device
JP2004516067A (en) 2000-12-19 2004-06-03 ヴァスキュラー・アーキテクツ・インコーポレイテッド Bioactive drug delivery device and method
US6565599B1 (en) 2000-12-28 2003-05-20 Advanced Cardiovascular Systems, Inc. Hybrid stent
US6540777B2 (en) 2001-02-15 2003-04-01 Scimed Life Systems, Inc. Locking stent
US20020138136A1 (en) 2001-03-23 2002-09-26 Scimed Life Systems, Inc. Medical device having radio-opacification and barrier layers
EP1245203B1 (en) 2001-03-30 2006-03-08 Terumo Kabushiki Kaisha Stent
US6629994B2 (en) 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US8197535B2 (en) 2001-06-19 2012-06-12 Cordis Corporation Low profile improved radiopacity intraluminal medical device
US20020198589A1 (en) 2001-06-22 2002-12-26 Leong Veronica Jade Tessellated stent and method of manufacture
US6605110B2 (en) 2001-06-29 2003-08-12 Advanced Cardiovascular Systems, Inc. Stent with enhanced bendability and flexibility
US6979346B1 (en) 2001-08-08 2005-12-27 Advanced Cardiovascular Systems, Inc. System and method for improved stent retention
US20030055485A1 (en) 2001-09-17 2003-03-20 Intra Therapeutics, Inc. Stent with offset cell geometry
WO2003055414A1 (en) 2001-10-18 2003-07-10 Advanced Stent Technologies, Inc. Stent for vessel support, coverage and side branch accessibility
DE10201151B4 (en) 2002-01-15 2007-10-04 Qualimed Innovative Medizinprodukte Gmbh Stent with marker
GB0206061D0 (en) 2002-03-14 2002-04-24 Angiomed Ag Metal structure compatible with MRI imaging, and method of manufacturing such a structure
US7691461B1 (en) 2002-04-01 2010-04-06 Advanced Cardiovascular Systems, Inc. Hybrid stent and method of making
US7195648B2 (en) 2002-05-16 2007-03-27 Cordis Neurovascular, Inc. Intravascular stent device
US20030225448A1 (en) 2002-05-28 2003-12-04 Scimed Life Systems, Inc. Polar radiopaque marker for stent
US20040015229A1 (en) 2002-07-22 2004-01-22 Syntheon, Llc Vascular stent with radiopaque markers
US6969402B2 (en) 2002-07-26 2005-11-29 Syntheon, Llc Helical stent having flexible transition zone
US6878162B2 (en) 2002-08-30 2005-04-12 Edwards Lifesciences Ag Helical stent having improved flexibility and expandability
WO2004019820A1 (en) 2002-08-30 2004-03-11 Advanced Cardiovascular Systems, Inc. Stent with nested rings
US7135038B1 (en) 2002-09-30 2006-11-14 Advanced Cardiovascular Systems, Inc. Drug eluting stent
US7331986B2 (en) 2002-10-09 2008-02-19 Boston Scientific Scimed, Inc. Intraluminal medical device having improved visibility
US7223283B2 (en) * 2002-10-09 2007-05-29 Boston Scientific Scimed, Inc. Stent with improved flexibility
US8105373B2 (en) 2002-12-16 2012-01-31 Boston Scientific Scimed, Inc. Flexible stent with improved axial strength
ES2392712T3 (en) 2002-12-17 2012-12-13 Fluor Corporation Procedure for the removal of acid gas and pollutants with near zero emission
US7771463B2 (en) 2003-03-26 2010-08-10 Ton Dai T Twist-down implant delivery technologies
US6846323B2 (en) 2003-05-15 2005-01-25 Advanced Cardiovascular Systems, Inc. Intravascular stent
US20040236409A1 (en) 2003-05-20 2004-11-25 Pelton Alan R. Radiopacity intraluminal medical device
AU2004243014B2 (en) 2003-05-23 2009-12-10 Boston Scientific Limited Stents with attached looped ends
DE10325678A1 (en) 2003-06-02 2004-12-23 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Connection system for connecting a stent to a radio-opaque marker and method for establishing a connection between a stent and two or more radio-opaque markers
US20040254637A1 (en) 2003-06-16 2004-12-16 Endotex Interventional Systems, Inc. Sleeve stent marker
US7479157B2 (en) 2003-08-07 2009-01-20 Boston Scientific Scimed, Inc. Stent designs which enable the visibility of the inside of the stent during MRI
US20050060025A1 (en) 2003-09-12 2005-03-17 Mackiewicz David A. Radiopaque markers for medical devices
US7175654B2 (en) 2003-10-16 2007-02-13 Cordis Corporation Stent design having stent segments which uncouple upon deployment
US20050149168A1 (en) 2003-12-30 2005-07-07 Daniel Gregorich Stent to be deployed on a bend
US7021893B2 (en) 2004-01-09 2006-04-04 United Technologies Corporation Fanned trailing edge teardrop array
GB0400571D0 (en) 2004-01-12 2004-02-11 Angiomed Gmbh & Co Implant
JP4651625B2 (en) 2004-01-27 2011-03-16 メッド・インスティテュート・インコーポレイテッド Fixed barbs for attachment to medical prostheses
US7243408B2 (en) 2004-02-09 2007-07-17 Boston Scientific Scimed, Inc. Process method for attaching radio opaque markers to shape memory stent
TW200528463A (en) 2004-02-19 2005-09-01 Chung Shan Inst Of Science A method for preparing an bifunctional arylphosphonite antioxidant
US8034096B2 (en) 2004-03-31 2011-10-11 Cook Medical Technologies Llc Stent-graft with graft to graft attachment
BRPI0418719A (en) 2004-05-05 2007-09-11 Invatec Srl endoluminal prosthesis
US20050278017A1 (en) 2004-06-09 2005-12-15 Scimed Life Systems, Inc. Overlapped stents for scaffolding, flexibility and MRI compatibility
JP4844394B2 (en) 2004-06-25 2011-12-28 日本ゼオン株式会社 Stent
US7763066B2 (en) 2004-07-28 2010-07-27 Cook Incorporated Stent with an end member having a lateral extension
GB0417077D0 (en) 2004-07-30 2004-09-01 Angiomed Ag Medical implant such as a stent
GB0417078D0 (en) 2004-07-30 2004-09-01 Angiomed Ag Flexible implant
US20060064155A1 (en) 2004-09-01 2006-03-23 Pst, Llc Stent and method for manufacturing the stent
DE102004043166A1 (en) 2004-09-03 2006-03-09 Carl Baasel Lasertechnik Gmbh & Co. Kg Intravascular stent and method for its production
DE202004014789U1 (en) 2004-09-22 2005-01-27 Campus Medizin & Technik Gmbh Stent for implantation into or onto a hollow organ comprises a cutout serving as receptacle for a conical marker element which is X-ray opaque and is oriented radially relative to the stent axis
DE102004045994A1 (en) 2004-09-22 2006-03-30 Campus Gmbh & Co. Kg Stent for implantation in or around a hollow organ with marker elements made from a radiopaque material
WO2006036912A2 (en) 2004-09-27 2006-04-06 Echobio Llc Systems, apparatus and methods related to helical, non-helical or removable stents with rectilinear ends
US20060085065A1 (en) 2004-10-15 2006-04-20 Krause Arthur A Stent with auxiliary treatment structure
FR2879131B1 (en) 2004-12-14 2010-12-17 Saint Gobain COMPLEX GLAZING CONSISTS OF AT LEAST TWO CONTIGUOUS GLASS ELEMENTS AND METHOD FOR PRODUCING THE COMPLEX GLAZING.
US20060216431A1 (en) 2005-03-28 2006-09-28 Kerrigan Cameron K Electrostatic abluminal coating of a stent crimped on a balloon catheter
EP1707162B1 (en) * 2005-03-30 2010-04-28 Terumo Kabushiki Kaisha Stent
US7854760B2 (en) 2005-05-16 2010-12-21 Boston Scientific Scimed, Inc. Medical devices including metallic films
US20060265049A1 (en) 2005-05-19 2006-11-23 Gray Robert W Stent and MR imaging process and device
GB2430185A (en) 2005-09-17 2007-03-21 Barbara Ann Fraitis Refuse receptacle comprising sack-supporting device
NL1030013C2 (en) 2005-09-22 2007-03-23 Marcus Franciscus The Engelaar Device and method for placement of screws and pressure distribution members.
US20070112421A1 (en) 2005-11-14 2007-05-17 O'brien Barry Medical device with a grooved surface
GB0609841D0 (en) 2006-05-17 2006-06-28 Angiomed Ag Bend-capable tubular prosthesis
GB0609911D0 (en) 2006-05-18 2006-06-28 Angiomed Ag Bend-capable stent prosthesis
GB0613670D0 (en) 2006-07-10 2006-08-16 Angiomed Ag Tubular metal prosthesis and method of making it
GB0616579D0 (en) 2006-08-21 2006-09-27 Angiomed Ag Self-expanding stent
GB0616729D0 (en) 2006-08-23 2006-10-04 Angiomed Ag Method of welding a component to a shape memory alloy workpiece
EP2063824B1 (en) 2006-09-07 2020-10-28 Angiomed GmbH & Co. Medizintechnik KG Helical implant having different ends
FR2907587B1 (en) 2006-10-23 2008-12-26 Commissariat Energie Atomique MAGNETIC DEVICE WITH PERPENDICULAR ANIMATION AND INTERCOUNTING COMPENSATORY INTERCONNECTIVE LAYER.
GB0622465D0 (en) 2006-11-10 2006-12-20 Angiomed Ag Stent
GB0624419D0 (en) 2006-12-06 2007-01-17 Angiomed Ag Stenting ring with marker
GB0703379D0 (en) 2007-02-21 2007-03-28 Angiomed Ag Stent with radiopaque marker
GB0706499D0 (en) 2007-04-03 2007-05-09 Angiomed Ag Bendable stent
GB0717481D0 (en) 2007-09-07 2007-10-17 Angiomed Ag Self-expansible stent with radiopaque markers
US20090204203A1 (en) 2008-02-07 2009-08-13 Medtronic Vascular, Inc. Bioabsorbable Stent Having a Radiopaque Marker
WO2011126708A1 (en) 2010-04-06 2011-10-13 Boston Scientific Scimed, Inc. Endoprosthesis
ES2522265T3 (en) 2010-06-21 2014-11-14 Zorion Medical, Inc. Bioabsorbable Implants

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020116044A1 (en) * 2000-05-22 2002-08-22 Cottone, Robert John Self-expanding stent
US20050182477A1 (en) * 2001-12-20 2005-08-18 White Geoffrey H. Intraluminal stent and graft
US20060030934A1 (en) * 2002-12-24 2006-02-09 Novostent Corporation Vascular prosthesis having improved flexibility and nested cell delivery configuration
WO2007073413A1 (en) * 2005-12-23 2007-06-28 Boston Scientific Limited Stent

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10213327B2 (en) 2000-08-17 2019-02-26 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US9480587B2 (en) 2000-08-17 2016-11-01 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US8900290B2 (en) 2000-08-17 2014-12-02 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
USRE44463E1 (en) 2000-08-18 2013-08-27 Angiomed Gmbh & Co. Medizintechnik Kg Implant with attached element and method of making such an implant
US9155642B2 (en) 2006-05-17 2015-10-13 C.R. Bard, Inc. Bend-capable tubular prosthesis
US8403978B2 (en) 2006-05-17 2013-03-26 C. R. Bard, Inc. Bend-capable tubular prosthesis
US10849770B2 (en) 2006-05-17 2020-12-01 C. R. Bard, Inc. Bend-capable tubular prosthesis
US8574286B2 (en) 2006-05-18 2013-11-05 C. R. Bard, Inc. Bend-capable stent prosthesis
US10231854B2 (en) 2006-05-18 2019-03-19 C. R. Bard, Inc. Bend-capable stent prosthesis
US9364353B2 (en) 2006-05-18 2016-06-14 C.R. Bard, Inc. Bend-capable stent prosthesis
US8152842B2 (en) 2006-08-21 2012-04-10 C. R. Bard, Inc. Self-expanding stent
US8500793B2 (en) 2006-09-07 2013-08-06 C. R. Bard, Inc. Helical implant having different ends
US9084691B2 (en) 2006-11-10 2015-07-21 C. R. Bard, Inc. Stent
US10500075B2 (en) 2006-11-10 2019-12-10 C. R. Bard, Inc. Stent
US8551156B2 (en) 2006-11-10 2013-10-08 C. R. Bard, Inc. Stent
US8475520B2 (en) 2006-12-06 2013-07-02 C. R. Bard, Inc. Stenting ring with marker
US8518101B2 (en) 2007-04-03 2013-08-27 C. R. Bard, Inc. Bendable stent
US9050203B2 (en) 2007-04-03 2015-06-09 C. R. Bard, Inc. Bendable stent
WO2008119837A2 (en) 2007-04-03 2008-10-09 Angiomed Gmbh & Co. Medizintechnik Kg Bendable stent
WO2008119837A3 (en) * 2007-04-03 2009-03-12 Angiomed Ag Bendable stent
US10016291B2 (en) 2007-09-07 2018-07-10 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent
US8721709B2 (en) 2007-09-07 2014-05-13 C. R. Bard, Inc. Self-expansible stent with radiopaque markers and method of making such a stent
US8852262B2 (en) 2009-05-14 2014-10-07 C. R. Bard, Inc. Stent
WO2010130788A1 (en) * 2009-05-14 2010-11-18 Angiomed Gmbh & Co. Medizintechnik Kg Stent
WO2011034796A1 (en) * 2009-09-18 2011-03-24 Medtronic Vascular Inc. Stent with improved flexibility
US10231855B2 (en) 2010-08-02 2019-03-19 CARDINAL HEALTH SWITZERLAND 515 GmbH Flexible helical stent having intermediate non-helical region
US20120029621A1 (en) * 2010-08-02 2012-02-02 Schroeder Valeska Flexible helical stent having intermediate non-helical region

Also Published As

Publication number Publication date
US20100016949A1 (en) 2010-01-21
DE602007006026D1 (en) 2010-06-02
US9770348B2 (en) 2017-09-26
CA2690060C (en) 2014-10-28
EP2056744B1 (en) 2010-04-21
GB0616999D0 (en) 2006-10-04
CA2690060A1 (en) 2008-03-06
US9254207B2 (en) 2016-02-09
US20160151181A1 (en) 2016-06-02
EP2056744A1 (en) 2009-05-13

Similar Documents

Publication Publication Date Title
US9770348B2 (en) Annular mesh
US10500075B2 (en) Stent
EP2053990B1 (en) Self-expanding stent with axially staggered strut structure
US10433987B2 (en) Highly flexible stent and method of manufacture
EP2311411B1 (en) Stent having helical elements
US7635384B2 (en) Varying circumferential spanned connectors in a stent
CA2446358C (en) Improved stent
AU2003235619B2 (en) Stent
US8672995B2 (en) Polymer prosthesis
EP1572035B1 (en) Flexible stent with improved axial strength
US20130090719A1 (en) Highly Flexible Stent and Method of Manufacture
US20110166641A1 (en) Highly flexible stent and method of manufacture
US20130090721A1 (en) Highly Flexible Stent and Method of Manufacture
WO2008022950A1 (en) Method of welding a component to a shape memory alloy workpiece with provision of an extra cut for compensating the variations of dimension of workpiece and component

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07802941

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2690060

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007802941

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12438527

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU